Smith & Nephew (SNNUF) Share-based Compensation (2010 - 2024)
Smith & Nephew (SNNUF) reported Share-based Compensation of $20.0 million for Q4 2024, up 5.26% on a YoY basis from $19.0 million in Q1 2024, and up 5.26% quarter-over-quarter from $19.0 million in Q4 2023.
Smith & Nephew (SNNUF) Share-based Compensation (2010 - 2024) Analysis & Trends
Smith & Nephew has reported Share-based Compensation for 9 years, with the latest figure at $20.0 million in Q4 2024.
- For the quarter ending Q4 2024, Share-based Compensation rose 5.26% year-over-year to $20.0 million; the trailing twelve-month figure through Dec 2024 stood at $85.0 million (up 6.25% YoY), and the FY2025 full-year result was $43.0 million, up 7.5% from the prior year.
- Share-based Compensation for Q4 2024 stood at $20.0 million, up from $19.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $23.0 million in Q4 2021, with the low at $15.0 million in Q4 2020.
- Historically, Share-based Compensation has averaged $20.0 million across 5 years, with a median of $20.0 million in 2024.
- Annual changes were most pronounced in 2021 — Share-based Compensation jumped 53.33% — and 2023, when it declined 17.39%.
- Smith & Nephew's Share-based Compensation stood at $15.0 million in 2020, then surged by 53.33% to $23.0 million in 2021, then changed by 0.0% to $23.0 million in 2022, then decreased by 17.39% to $19.0 million in 2023, then gained by 5.26% to $20.0 million in 2024.
- The last three Share-based Compensation figures came in at $20.0 million (Q4 2024), $19.0 million (Q4 2023), and $23.0 million (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 35.12 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 20.00 Mn |
| Dec 31, 2024 | 20.00 Mn |
| Dec 31, 2023 | 19.00 Mn |
| Dec 31, 2023 | 19.00 Mn |
| Dec 31, 2022 | 23.00 Mn |
| Dec 31, 2022 | 23.00 Mn |
| Dec 31, 2021 | 23.00 Mn |
| Dec 31, 2021 | 23.00 Mn |
| Dec 31, 2020 | 15.00 Mn |
| Dec 31, 2020 | 15.00 Mn |
| Dec 31, 2019 | 17.00 Mn |
| Dec 31, 2019 | 17.00 Mn |
| Dec 31, 2018 | 18.00 Mn |
| Dec 31, 2018 | 18.00 Mn |
| Dec 31, 2017 | 15.00 Mn |
| Dec 31, 2017 | 15.00 Mn |
| Dec 31, 2010 | 5.00 Mn |
| Dec 31, 2010 | 5.00 Mn |